Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of two core genes in glioblastomas with different isocitrate dehydrogenase mutation status.

Molecular biology reports - 1 Oct 2020

Guo Yuduo, Wang Xiang, Ning Weihai, Zhang Hongwei, Yu Chunjiang

Abstract excerpt

Glioblastoma (GBM) is one of the most common malignancies of the central nervous system, and the Isocitrate Dehydrogenase (IDH) mutation status of GBM has been recognized as a critical prognostic indicator. However, the molecular mechanism underlying the GBM with different IDH mutation status is still not unclear. In this study, a total of 353 DEGs including 207 up-regulated and 146 down-regulated were screened...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Databases, Nucleic Acid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Neoplasm Proteins

Share to Plasminogen Activator Inhibitor 1

Share to Tissue Inhibitor of Metalloproteinase-1

Source

Identifiers

PMID: 32915403
DOI: 10.1007/s11033-020-05804-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of two core genes in glioblastomas with different isocitrate dehydrogenase mutation status.PMID 32915403Read ↗

Identification of Potential Key Genes Associated with the Pathogenesis and Prognosis of Glioblastoma Based on Integrated Bioinformatics AnalysisSemantic proximity Read ↗

Identification of Key Genes and Signaling Pathways Associated with the Progression of Glioblastoma multiformSemantic proximity Read ↗

Molecular classification of IDH-mutant glioblastomas based on gene expression profilesSemantic proximity Read ↗

Tumor Heterogeneity and Molecular Characteristics of Glioblastoma Revealed by Single-Cell RNA-Seq Data AnalysisSemantic proximity Read ↗

In-Depth Summary of Intersected Hub-Genes Between Low-Grade and High-Grade Gliomas, from Bioinformatics and Literature ReportsSemantic proximity Read ↗

Identification of novel genes associated with diagnosis and prognosis in glioblastomaSemantic proximity Read ↗

Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technologySemantic proximity Read ↗

Integrated Transcriptome Profiling Identifies Prognostic Hub Genes as Therapeutic Targets of Glioblastoma: Evidenced by Bioinformatics AnalysisSemantic proximity Read ↗

Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastomaSemantic proximity Read ↗

Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogenase-1 and tumor protein 53 mutations.Semantic proximity Read ↗

Bioinformatic Identification of a Six-Gene Biomarker Signature for Prognostic and Diagnostic Insight in GlioblastomaSemantic proximity Read ↗

Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.